Ascendis Pharma Financial Overview
Ascendis Pharma's market cap is currently $12.80B. The company's EPS TTM is $-1.180596; its P/E ratio is ―; Ascendis Pharma is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
